Wakimoto Pharmaceutical Co., Ltd.
Basic information
- Head office
- 2-2-2 Nihonbashi-Honcho, Chuo-ku, Tokyo 103-8330, Japan
- Chief executive
- Tomoyuki Hirai
- Capital
- 3,395,000,000 (33 100 million)
- Employees (non-consolidated)
- 286 people
- Employees (consolidated)
- 425 people
- Start date
- 1929-04-01
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| 株式会社わかもと本舗栄養と育児の会 | ||||||||
| 株式会社栄養と育児の会 | ||||||||
| アバンビーズ | ||||||||
| アバンビーズ オーラルタブレット | ||||||||
| アレジフェンス | ||||||||
| コーラルε | ||||||||
| フェミフローラ | ||||||||
| フェミフローラ 大豆イソフラボン マカ&ギャバ | ||||||||
| フェミフローラ 葉酸プラス | ||||||||
| フェミフローライン デリケート保湿クリーム | ||||||||
| 強力わかもと | ||||||||
| 顆粒わかもと |
Network
History
April 1929: Established the partnership company "Nutrition and Childcare Association" at Shiba Park, Shiba-ku, Tokyo, and launched "Wakimoto".![]()
Established a joint‑stock company "Nutrition and Childcare Association" at Daimon, Shiba Park, Shiba‑ku, Tokyo City, and launched "Wakamoto".![]()
January 1933: Established "Nutrition and Childcare Association Co., Ltd." in Shiba Park, Shiba-ku, Tokyo, and began manufacturing and selling the digestive, intestinal, and nutritional agent "Wakimoto".![]()
Established "Corporation Nutrition and Childcare Association" in Shiba Park, Shiba‑ku, Tokyo City, and began manufacturing and selling the digestive, intestinal health, and nutrition agent "Wakamoto".![]()
December 1935: Renamed the company to "Wakimoto Honpo Nutrition and Childcare Association Co., Ltd.".![]()
Since its founding, our company has developed products that contribute to the health maintenance of the public by utilizing lactic acid bacteria technology. In 1955, we incorporated lactic acid bacteria into "Wakamoto".![]()
January 1962: Released "Kouryoku Wakimoto", an enhanced product featuring digestive enzymes, active lactic acid bacteria, vitamins B1 and B2, and nicotinamide.![]()
Released 'Strong Wakamoto' with enhanced digestive enzymes, active lactic acid bacteria, vitamins B1, B2, and nicotinamide![]()
June 1968: Established the Sagami-Oi factory and research facilities in Oi-machi, Sagamihara, Kanagawa Prefecture.![]()
Established the Sagami Oi factory and research facilities in Oi-machi, Sagamihara, Kanagawa Prefecture![]()
In 1970, we began selling the antibiotic and chemotherapy‑resistant lactic acid bacteria formulation "Rebenin".![]()
January 1989: Issued the first series of secured convertible bonds with a total face value of 4 billion yen.![]()
May 1989: Released the water-soluble non-steroidal anti-inflammatory eye drop "Dicloid Eye Drops 0.1%".![]()
In 1995, we sold "Wakamoto Intestinal Health Medicine", the first over‑the‑counter product to incorporate two strains of Bifidobacteria.![]()
Sold 'Wakamoto Intestinal Health Medicine', the first over-the-counter drug to combine two Bifidobacterium strains.![]()
December 1995: Released the lactic acid bacteria intestinal regulator "Wakimoto Intestinal Medicine".![]()
November 1999: Released "Rizmon TG Eye Drops", the world's first heat-responsive gel technology eye drop for glaucoma and ocular hypertension.![]()
Released the world's first thermoresponsive gel technology eye drop, glaucoma and ocular hypertension treatment 'Rizmon TG Eye Drop'![]()
August 2002: Obtained ISO 14001 certification for the environmental management system at the Sagami-Oi factory.![]()
In 2005, we sold "AvanBees", the first Japanese medicated toothpaste containing live lactic acid bacteria.![]()
July 2007: Release of the glaucoma and ocular hypertension treatment drug "Nipradilol eye drops 0.25% 'Wakamoto'" (first product to adopt preservative‑free NP container).![]()
Released glaucoma and ocular hypertension treatment 'Nipradilol 0.25% Wakamojo' (first product to use preservative-free NP container)![]()
December 2010: Release of ophthalmic surgery adjunct "MakuAid intravitreal injection 40mg" (now ophthalmic surgery adjunct and ophthalmic corticosteroid "MakuAid eye injection 40mg").![]()
Released ophthalmic surgery adjunct 'MakuAid intravitreal injection 40mg' (now ophthalmic surgery adjunct and ophthalmic adrenal cortex hormone 'MakuAid eye injection 40mg')![]()
In 2017, we sold "AvanBees Oral Tablet", a processed food with a new lactic acid bacteria formulation suitable for oral care.![]()
Developed products applying proprietary fermentation and cultivation technologies centered on 'Strong Wakamoto'.![]()
Since 2023, we have begun selling femcare products (supplements, protein, etc.) that can be easily incorporated into daily life and provide counseling for women's concerns, thereby developing new businesses.![]()
Launched femcare products (supplements, protein, etc.) that can be easily incorporated into daily life and provide women's counseling, creating a new business.![]()
June 2025: Release of multifocal intraocular lens "Aciravitrova Pro (Non‑toric)" featuring sinusoidal diffraction structure.![]()
News
There is no news.
Public records
National Tax Agency basic information1010001035010
- Trade name
- わかもと製薬株式会社
- Trade name (kana)
- ワカモトセイヤク
- Name in English
- Corporation type
- 301
- Address
- 〒103-0023 東京都中央区日本橋本町2丁目2番2号
- Postal code
- 1030023
- Prefecture code
- 13
- City code
- 102
- Address outside Japan
- Prefecture in English
- City in English
- Address outside Japan in English
- Corporate number assignment date
- 2015-10-05
- Update date
- 2018-04-10
- Change date
- 2015-10-05
- Registry closure date
- Reason for registry closure
- Successor corporate number
- Details of the change
- Latest record
- 1
- Excluded from search
- 0
- Processing type
- 01
- Correction type
- 1
- Trade name image ID
- Address image ID
- Sequence number
- 1271608
METI gBizINFO1010001035010
- Corporate number
- 1010001035010
- Trade name
- わかもと製薬株式会社
- Trade name (kana)
- ワカモトセイヤク
- Trade name (alphabet)
- Registry closure date
- Reason for registry closure
- Registered address
- 東京都中央区日本橋本町2丁目2番2号
- Postal code
- 1030023
- Prefecture
- 東京都
- Prefecture code
- 13
- City or district
- 中央区
- City code
- 102
- Street address
- 日本橋本町2丁目2番2号
- Organisation type
- 301
- Processing type
- 01
- Correction type
- 1
- Status
- Representative
- 代表取締役社長 平井 友行
- Capital
- 3395887000
- Employees
- 303
- Employees (male)
- Employees (female)
- Business summary
- Website URL
- Year founded
- Business category
- Date established
- Unified government qualification - grade
- Unified government qualification - business items
- Update date
- 2018-04-10
- Key information
- 1010001035010